REXNESVY Trademark

Trademark Overview


On Tuesday, August 9, 2022, a trademark application was filed for REXNESVY with the United States Patent and Trademark Office. The USPTO has given the REXNESVY trademark a serial number of 97541148. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Glaxo Group Limited. The REXNESVY trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
rexnesvy

General Information


Serial Number97541148
Word MarkREXNESVY
Filing DateTuesday, August 9, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, August 12, 2022NEW APPLICATION ENTERED
Monday, August 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 20, 2023ASSIGNED TO EXAMINER
Saturday, May 20, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, May 20, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, May 20, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, May 20, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, June 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 4, 2024SOU EXTENSION 1 GRANTED
Monday, March 4, 2024SOU EXTENSION 1 FILED
Tuesday, March 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, September 5, 2024NOTICE OF ALLOWANCE CANCELLED
Tuesday, September 24, 2024ASSIGNED TO PETITION STAFF
Thursday, September 26, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, September 26, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, October 4, 2024CASE RETURNED TO EXAMINATION
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED